Package 63539-012-02

Brand: xeljanz

Generic: tofacitinib
NDC Package

Package Facts

Identity

Package NDC 63539-012-02
Digits Only 6353901202
Product NDC 63539-012
Product ID 63539-012_c422393a-1e5c-46d2-81df-3d05818bf50e
Description

60 TABLET, FILM COATED in 1 BOTTLE (63539-012-02)

Marketing

Marketing Status
Marketed Since 2012-11-08
Brand xeljanz
Generic tofacitinib
Sample Package No

Linked Drug Pages (1)

XELJANZ, XELJANZ XR ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c422393a-1e5c-46d2-81df-3d05818bf50e", "openfda": {"unii": ["O1FF4DIV0D"], "rxcui": ["1357541", "1357547", "1741046", "1741049", "2048566", "2048568", "2273113", "2273115", "2478433", "2478437"], "spl_set_id": ["68e3d6b2-7838-4d2d-a417-09d919b43e13"], "manufacturer_name": ["U.S. Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (63539-012-02)", "package_ndc": "63539-012-02", "marketing_start_date": "20121108"}], "brand_name": "XELJANZ", "product_id": "63539-012_c422393a-1e5c-46d2-81df-3d05818bf50e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Janus Kinase Inhibitor [EPC]", "Janus Kinase Inhibitors [MoA]"], "product_ndc": "63539-012", "generic_name": "tofacitinib", "labeler_name": "U.S. Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "XELJANZ", "active_ingredients": [{"name": "TOFACITINIB CITRATE", "strength": "5 mg/1"}], "application_number": "NDA203214", "marketing_category": "NDA", "marketing_start_date": "20121108", "listing_expiration_date": "20271231"}